EPISODE · Jun 15, 2022 · 9 MIN
In conversation with... Elise Meima-van Praag
from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet
Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.
NOW PLAYING
In conversation with... Elise Meima-van Praag
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m